本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aclaris Therapeutics

5.40
+0.08001.50%
盤後5.400.00000.00%16:20 EDT
成交量:381.71萬
成交額:2,083.87萬
市值:7.95億
市盈率:-9.21
高:5.63
開:5.37
低:5.34
收:5.32
52周最高:6.60
52周最低:1.74
股本:1.47億
流通股本:1.10億
量比:1.04
換手率:3.47%
股息:- -
股息率:- -
每股收益(TTM):-0.5861
每股收益(LYR):-0.5300
淨資產收益率:-59.10%
總資產收益率:-28.98%
市淨率:6.38
市盈率(LYR):-10.19

資料載入中...

2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/24

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/14

重要事件披露

8-K - Current report
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/22

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/02

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/26

重要事件披露

8-K - Current report
2021/06/11

重要事件披露

8-K - Current report
2021/06/08

重要事件披露

8-K - Current report
2021/06/03

重要事件披露

8-K - Current report
2021/05/20

重要事件披露

8-K - Current report
2021/05/07

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/07

重要事件披露

8-K - Current report
2021/02/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals